Guild Learning and Development is partnering with AbbVie Pty Ltd in an online course titled “Understanding biologic medicines”
AbbVie’s General Manager Kirsten O’Doherty says the course plays an important role in supporting pharmacists to further develop their understanding of biologic medicines, ensuring they are confident when having conversations about the key clinical considerations related to the therapeutic use of these complex medicines.
“AbbVie is committed to helping pharmacists have resources and training so they can best meet the needs of the patients they serve,” she says.
This course examines the evolving landscape and key clinical considerations regarding biologic medicines and is intended to provide pharmacists with practical tips to help engage with patients that are using biologic medicines.
Biologic medicines are used to treat a range of acute and chronic conditions, including cancer, autoimmune diseases, diabetes and multiple sclerosis.
Managing patients on biologic medicines and maintaining disease stability is inherently complicated due to a range of factors including the complexity of the drug itself, the mode of action and patient-specific factors.
It is therefore important that all members of a patient’s healthcare team, including pharmacists, be aware of the complexities surrounding biologics to ensure optimum patient outcomes.
National President of the Pharmacy Guild of Australia, George Tambassis, says that in the very near future biologics would become a significant part of medicines supplied by community pharmacy.
“Pharmacists need to have a comprehensive understanding of both originator biologics and biosimilars so that they can form a balanced and expert opinion on all options available to their patients,” he says.
This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1 hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.
Guild Learning and Development has thanked AbbVie Pty Ltd for their financial support and assistance in the development of this course.